HK1212678A1 - 雙氰胺前體藥物 - Google Patents
雙氰胺前體藥物Info
- Publication number
- HK1212678A1 HK1212678A1 HK16100480.9A HK16100480A HK1212678A1 HK 1212678 A1 HK1212678 A1 HK 1212678A1 HK 16100480 A HK16100480 A HK 16100480A HK 1212678 A1 HK1212678 A1 HK 1212678A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cyanoguanidine
- prodrugs
- cyanoguanidine prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25207800P | 2000-11-21 | 2000-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1212678A1 true HK1212678A1 (zh) | 2016-06-17 |
Family
ID=22954502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05105842A HK1073297A1 (en) | 2000-11-21 | 2005-07-11 | Cyanoguanidine prodrugs |
| HK16100480.9A HK1212678A1 (zh) | 2000-11-21 | 2016-01-15 | 雙氰胺前體藥物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05105842A HK1073297A1 (en) | 2000-11-21 | 2005-07-11 | Cyanoguanidine prodrugs |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6525077B2 (zh) |
| EP (2) | EP2894149B1 (zh) |
| JP (1) | JP4521157B2 (zh) |
| KR (1) | KR100871577B1 (zh) |
| CN (1) | CN100368401C (zh) |
| AU (3) | AU1494702A (zh) |
| BR (1) | BR0115514A (zh) |
| CA (1) | CA2426601C (zh) |
| CZ (1) | CZ305764B6 (zh) |
| ES (2) | ES2549260T3 (zh) |
| HK (2) | HK1073297A1 (zh) |
| HU (1) | HU230544B1 (zh) |
| IL (2) | IL155483A0 (zh) |
| MX (1) | MXPA03004394A (zh) |
| PL (1) | PL224371B1 (zh) |
| RU (1) | RU2312858C2 (zh) |
| WO (2) | WO2002042265A2 (zh) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711123D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| US20030045515A1 (en) * | 2001-05-24 | 2003-03-06 | Lise Binderup | Combination medicament for treatment of neoplastic diseases |
| RU2326867C2 (ru) * | 2002-05-17 | 2008-06-20 | Лео Фарма А/С | Цианогуанидиновые производные, способ лечения и фармацевтическая композиция на их основе |
| US7253193B2 (en) | 2002-05-17 | 2007-08-07 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| RU2004136989A (ru) * | 2002-05-17 | 2005-06-27 | Лео Фарма А/С (Dk) | Цианогуанидиновые пролекарства |
| US20050101576A1 (en) * | 2003-11-06 | 2005-05-12 | Novacea, Inc. | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes |
| EA012240B1 (ru) * | 2003-04-03 | 2009-08-28 | Семафор Фармасьютикалз, Инк. | Пролекарства ингибиторов киназы pi-3 |
| ES2572777T3 (es) | 2004-12-22 | 2016-06-02 | Leo Pharma A/S | Compuestos novedosos de cianoguanidina |
| WO2007022964A2 (de) | 2005-08-24 | 2007-03-01 | Abbott Gmbh & Co. Kg | Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| WO2009072004A2 (en) * | 2007-09-26 | 2009-06-11 | Gemin X Pharmaceuticals Canada, Inc. | Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| US8173677B2 (en) * | 2007-09-26 | 2012-05-08 | Gemin X Pharmaceuticals Canada Inc. | Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| US8101606B2 (en) | 2007-11-12 | 2012-01-24 | Washington University | Neurofibromin pathway modulators |
| JP5688367B2 (ja) | 2008-08-29 | 2015-03-25 | トポターゲット・アクティーゼルスカブＴｏｐｏＴａｒｇｅｔ Ａ／Ｓ | 新規なウレアおよびチオウレア誘導体 |
| WO2010088842A1 (zh) | 2009-02-06 | 2010-08-12 | 天津和美生物技术有限公司 | 含有吡啶基氰基胍的药物组合物及其制备和应用 |
| WO2011006988A1 (en) | 2009-07-17 | 2011-01-20 | Topotarget A/S | Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors |
| US9224007B2 (en) * | 2009-09-15 | 2015-12-29 | International Business Machines Corporation | Search engine with privacy protection |
| US9600134B2 (en) | 2009-12-29 | 2017-03-21 | International Business Machines Corporation | Selecting portions of computer-accessible documents for post-selection processing |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| WO2011121055A1 (en) | 2010-03-31 | 2011-10-06 | Topotarget A/S | Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety |
| TW201216963A (en) | 2010-09-03 | 2012-05-01 | Forma Therapeutics Inc | Novel compounds and compositions for the inhibition of NAMPT |
| ES2779225T3 (es) * | 2011-04-08 | 2020-08-14 | Sphaera Pharma Pte Ltd | Reactivos de merilformilo sustituido y procedimiento de uso de los mismos para modificar propiedades fisicoquímicas y/o farmacocinéticas de compuestos |
| US9195853B2 (en) | 2012-01-15 | 2015-11-24 | International Business Machines Corporation | Automated document redaction |
| CN104583206A (zh) * | 2012-06-15 | 2015-04-29 | 加利福尼亚大学董事会 | 用于脑癌的新颖治疗剂 |
| MX2015000101A (es) * | 2012-06-27 | 2015-06-22 | Alzheimer S Inst Of America Inc | Compuestos y usos terapéuticos de los mismos. |
| WO2014055938A1 (en) | 2012-10-04 | 2014-04-10 | Inhibikase Therapeutics, Inc. | Novel compounds, their preparation and their uses |
| US9892278B2 (en) | 2012-11-14 | 2018-02-13 | International Business Machines Corporation | Focused personal identifying information redaction |
| US10227333B2 (en) | 2015-02-11 | 2019-03-12 | Curtana Pharmaceuticals, Inc. | Inhibition of OLIG2 activity |
| IL254007B1 (en) | 2015-02-27 | 2024-04-01 | Curtana Pharmaceuticals Inc | Inhibition of OLIG2 activity |
| WO2017162536A1 (en) | 2016-03-21 | 2017-09-28 | H. Lundbeck A/S | Vortioxetine prodrugs |
| US20200138964A1 (en) * | 2017-04-25 | 2020-05-07 | Seikagaku Corporation | Tertiary amine compound or imine compound-polymer conjugate and production method therefor |
| EP3590927A1 (en) * | 2018-07-05 | 2020-01-08 | Bayer Animal Health GmbH | Novel compounds for controlling arthropods |
| US11136295B2 (en) * | 2018-10-29 | 2021-10-05 | Kempharm, Inc. | D-amphetamine compounds, compositions, and processes for making and using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05501103A (ja) * | 1989-06-26 | 1993-03-04 | ザ・リサーチ・ファウンデーション・オヴ・ステイト・ユニヴァーシティ・オヴ・ニューヨーク | ビス―アシルオキシメチル誘導体 |
| GB9219472D0 (en) | 1992-09-15 | 1992-10-28 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9607219D0 (en) * | 1996-04-04 | 1996-06-12 | Smithkline Beecham Plc | Novel compounds |
| GB9711124D0 (en) | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711123D0 (en) | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711119D0 (en) | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711125D0 (en) | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| AU4076500A (en) * | 1999-04-09 | 2000-11-14 | Shionogi Bioresearch Corp. | (n)-substituted cyanoguanidine compounds |
| WO2000061561A1 (en) * | 1999-04-09 | 2000-10-19 | Shionogi Bioresearch Corp. | Cyanoguanidine compounds |
-
2001
- 2001-11-12 AU AU1494702A patent/AU1494702A/xx active Pending
- 2001-11-14 MX MXPA03004394A patent/MXPA03004394A/es active IP Right Grant
- 2001-11-14 IL IL15548301A patent/IL155483A0/xx unknown
- 2001-11-14 RU RU2003118446/04A patent/RU2312858C2/ru active
- 2001-11-14 EP EP15150976.7A patent/EP2894149B1/en not_active Expired - Lifetime
- 2001-11-14 JP JP2002544401A patent/JP4521157B2/ja not_active Expired - Lifetime
- 2001-11-14 EP EP01983436.5A patent/EP1339686B1/en not_active Expired - Lifetime
- 2001-11-14 AU AU2002214947A patent/AU2002214947B2/en not_active Expired
- 2001-11-14 CZ CZ2003-1303A patent/CZ305764B6/cs not_active IP Right Cessation
- 2001-11-14 PL PL362864A patent/PL224371B1/pl unknown
- 2001-11-14 CN CNB018192440A patent/CN100368401C/zh not_active Expired - Lifetime
- 2001-11-14 HU HU0400564A patent/HU230544B1/hu unknown
- 2001-11-14 KR KR1020037006880A patent/KR100871577B1/ko active IP Right Grant
- 2001-11-14 CA CA2426601A patent/CA2426601C/en not_active Expired - Lifetime
- 2001-11-14 WO PCT/DK2001/000750 patent/WO2002042265A2/en active IP Right Grant
- 2001-11-14 ES ES01983436.5T patent/ES2549260T3/es not_active Expired - Lifetime
- 2001-11-14 BR BR0115514-8A patent/BR0115514A/pt active Pending
- 2001-11-14 ES ES15150976.7T patent/ES2643083T3/es not_active Expired - Lifetime
- 2001-11-20 WO PCT/DK2001/000770 patent/WO2002042276A1/en not_active Application Discontinuation
- 2001-11-20 US US09/988,819 patent/US6525077B2/en not_active Expired - Lifetime
- 2001-11-20 AU AU2002223511A patent/AU2002223511A1/en not_active Abandoned
-
2003
- 2003-04-15 IL IL155483A patent/IL155483A/en active IP Right Grant
-
2005
- 2005-07-11 HK HK05105842A patent/HK1073297A1/xx not_active IP Right Cessation
-
2016
- 2016-01-15 HK HK16100480.9A patent/HK1212678A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212678A1 (zh) | 雙氰胺前體藥物 | |
| IL151073A0 (en) | Antiviral prodrugs | |
| GB0002847D0 (en) | Ampligier arrangement | |
| AU3391801A (en) | Pyridinylimidazoles | |
| DZ3293A1 (fr) | Arylpyrazines substitues | |
| AU8274301A (en) | Electro-powder | |
| AU6227101A (en) | Substituted iminoazines | |
| IL151010A0 (en) | Linezolid-crystal form ii | |
| PL358119A1 (en) | Substituted phenyluracils | |
| PL372761A1 (en) | Cyanoguanidine prodrugs | |
| AU5825501A (en) | Substituted benzoylcyclohexenones | |
| AU6619001A (en) | Liquid-pourers | |
| EP1343494A4 (en) | PROMOTERS TETRAPARTATES | |
| AU4686401A (en) | Hypotensors | |
| AU4831301A (en) | Gm-negative ehv-mutants | |
| AU2360402A (en) | Substituted phenyluracils | |
| GB0111284D0 (en) | Grating | |
| SI1261613T1 (en) | Gastro-specific prodrugs | |
| AU1702P (en) | Trailblazer Xanthostemon chrysanthus | |
| AU1852P (en) | Tickit xTriticosecale | |
| AU2117P (en) | Gauka Gaura lindheimeri | |
| GB0027368D0 (en) | Order form | |
| GB0015193D0 (en) | Advance arrangement | |
| GB0015191D0 (en) | Advance arrangement | |
| GB0130486D0 (en) | Windbeater one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20211113 |